D. Perroni

483 total citations
10 papers, 205 citations indexed

About

D. Perroni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, D. Perroni has authored 10 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in D. Perroni's work include Cancer Treatment and Pharmacology (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Breast Cancer Treatment Studies (2 papers). D. Perroni is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Breast Cancer Treatment Studies (2 papers). D. Perroni collaborates with scholars based in Italy, Netherlands and United States. D. Perroni's co-authors include Luigi Dogliotti, Alfredo Berruti, Francesco Minuto, Giulio Giordano, Donata Casadei Giunchi, A. Farris, Oriana Nanni, Aldo Becciolini, Angelo Gambi and Dino Amadori and has published in prestigious journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment and European Journal of Endocrinology.

In The Last Decade

D. Perroni

9 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Perroni Italy 8 141 78 42 42 33 10 205
G Pastorino Italy 9 162 1.1× 47 0.6× 57 1.4× 28 0.7× 47 1.4× 21 267
Maria Teresa Ionta Italy 11 107 0.8× 59 0.8× 53 1.3× 23 0.5× 77 2.3× 24 230
A. Pelegrí Spain 8 119 0.8× 98 1.3× 44 1.0× 25 0.6× 34 1.0× 12 211
Þorvaldur Jónsson Iceland 6 129 0.9× 44 0.6× 36 0.9× 18 0.4× 36 1.1× 13 224
Jawhar Rawwas United States 8 39 0.3× 67 0.9× 44 1.0× 18 0.4× 130 3.9× 11 245
N Sato Japan 6 40 0.3× 40 0.5× 28 0.7× 13 0.3× 104 3.2× 17 421
Nieves Martínez Lago Spain 8 121 0.9× 33 0.4× 51 1.2× 18 0.4× 40 1.2× 44 165
Alan C. Homans United States 8 33 0.2× 24 0.3× 89 2.1× 23 0.5× 78 2.4× 13 259
Peter Capell United States 5 167 1.2× 22 0.3× 50 1.2× 50 1.2× 63 1.9× 8 454

Countries citing papers authored by D. Perroni

Since Specialization
Citations

This map shows the geographic impact of D. Perroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Perroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Perroni more than expected).

Fields of papers citing papers by D. Perroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Perroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Perroni. The network helps show where D. Perroni may publish in the future.

Co-authorship network of co-authors of D. Perroni

This figure shows the co-authorship network connecting the top 25 collaborators of D. Perroni. A scholar is included among the top collaborators of D. Perroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Perroni. D. Perroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Brizzi, Maria Pia, Alfredo Berruti, Annamaria Ferrero, et al.. (2009). Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network. BMC Cancer. 9(1). 388–388. 48 indexed citations
2.
Bumma, C., et al.. (2009). Neoadjuvant Chemotherapy. PubMed. 43(18 Suppl). 158–176.
3.
Amadori, Dino, Oriana Nanni, Annalisa Volpi, et al.. (2007). Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis. Breast Cancer Research and Treatment. 108(2). 259–264. 9 indexed citations
4.
Dogliotti, Luigi, Maria Pia Brizzi, Annamaria Ferrero, et al.. (2007). Phase II trial of continuous/metronomic 5-fluorouracil infusion plus long acting Octreotide in advanced neuroendocrine carcinoma. Journal of Clinical Oncology. 25(18_suppl). 15003–15003. 1 indexed citations
5.
Amadori, Dino, Oriana Nanni, M. Marangolo, et al.. (2000). Disease-Free Survival Advantage of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Patients With Node-Negative, Rapidly Proliferating Breast Cancer: A Randomized Multicenter Study. Journal of Clinical Oncology. 18(17). 3125–3134. 43 indexed citations
6.
Berruti, Alfredo, Paolo Zola, A. Farris, et al.. (1997). Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival.. PubMed. 17(4A). 2763–8. 17 indexed citations
7.
Dogliotti, Luigi, Alfredo Berruti, Paolo Zola, et al.. (1996). Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial.. Journal of Clinical Oncology. 14(4). 1165–1172. 44 indexed citations
8.
Bretti, S., Alfredo Berruti, G. Gorzegno, et al.. (1996). Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients. Lung Cancer. 14(2-3). 353–360. 14 indexed citations
9.
Perroni, D., et al.. (1993). Right ventricular metastasis from choriocarcinoma: report of a rare case and review of the literature.. PubMed. 19(4). 378–81. 10 indexed citations
10.
Giordano, Giulio, et al.. (1976). GROWTH HORMONE AND SOMATOMEDIN BEHAVIOUR IN THE NEWBORN. European Journal of Endocrinology. 81(2). 449–454. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026